Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just an observation, i’m not sure what it means. Not only did MindMed (MMED) and Numinus (NUMI) have a drop at around 10:58am very similar to Revive Therapeutics (RVVTF) but others did as well, although their patterns might not appear as similarly obvious or as drastic.
The others that had a drop around the same time were Compass Pathways (CMPS), Field Trip Health (FTRP), Mind Cure Health (MCUR), HAVN Life Sciences (HAVN), and Psyched Wellness (PSYC). All of which will be a part of Horizons’ Psychedelics ETF.
This is the list of companies to be included in Horizons’ Psychedelics ETF.
Johnson & Johnson (JNJ)
AbbVie Inc (ABBV)
COMPASS Pathways (CMPS)
Field Trip Health (FTRP)
MindMed (MMED)
Greenbrook TMS Inc (GTMS)
Entheon Biomedical (ENBI)
Seelos Therapeutics (SEEL)
Cybin (CYBN)
Mind Cure Health (MCUR)
Havn Life Sciences (HAVN)
Numinus (NUMI)
Mydecine Innovations (MYCO)
Nova Mentis (NOVA)
Psyched Wellness (PSYC)
Revive Therapeutics (RVV)
Red Light Holland (TRIP)
Along with MindMed(MMED), Numinus(NUMI), Cybin(CYBN), and Revive Therapeutics(RVVTF)…
Field Trip Health(FTRP), Mind Cure Health(MCUR), Havn Life Sciences(HAVN), Mydecine Innovations(MYCO), Psyched Wellness(PSYC), and Red Light Holland(TRIP) have also announced bought deal offerings over the past weeks…2 of those deals being announced today after the market closed.
I posted this earlier today.
((“Taken from a post on Yahoo.
"Is it too far fetched to think these public offerings are related to the upcoming etf!? Mmed, numi, cybin, and now Rvv have gotten millions in $$ in exchange for shares in the past 2ish weeks."”))
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161074260
==================================================================
I concur with the above post from Yahoo and believe the bought deal offering has more do to with the upcoming ETF than RVVTF simply trying to raise capital at this time. And, I believe RVVTF was probably approached to do the offering.
I looked into the other companies mentioned in the post from Yahoo.
MindMed (MMED) closed on a bought deal offering on January 7, 2021. Canaccord Genuity Corp was the lead Underwriter along with Eight Capital and CIBC Capital Markets.
https://mindmed.co/news/press-release/mindmed-closes-upsized-financing-of-cad-92-1m-usd-72-7m-to-meet-high-investor-demand/
Numinus Wellness Inc (NUMI) closed on a bought deal offering on December 29, 2020. Canaccord Genuity Corp. and Eight Capital were the Underwriters.
https://numinus.ca/investors/news-release/numinus-announces-closing-of-17-million-bought-deal-offering-including-full-exercise-of-over-allotment-option
Cybin Inc (CYBN) announced a bought deal offering on January 18, 2021. Canaccord Genuity Corp is the lead Underwriter.
https://www.newswire.ca/news-releases/cybin-announces-cdn-20-million-bought-deal-offering-872605166.html
Revive Therapeutics - Co-Underwriters for the recent bought deal offering are Canaccord Genuity Corp. and Leede Jones Gable Inc.
Taken from a post on Yahoo.
"Is it too far fetched to think these public offerings are related to the upcoming etf!? Mmed, numi, cybin, and now Rvv have gotten millions in $$ in exchange for shares in the past 2ish weeks."
2 More clinical sites added.
Columbus Clinical Services
Miami, Florida, United States, 33125
OnSite Clinical Solutions
Charlotte, North Carolina, United States, 28208
https://clinicaltrials.gov/ct2/history/NCT04504734?A=10&B=11&C=Side-by-Side#StudyPageTop
The newest vaccines are supposed to protect the elderly against the Coronavirus? Well?
Health Experts Call For Suspension Of Pfizer Vaccination Among Elderly After Norway Deaths
https://www.zerohedge.com/covid-19/norway-sounds-alarm-over-vaccine-risks-elderly-frail-after-23-deaths
Why were US media silent on Pfizer vaccine deaths?: Global Times editorial
https://www.globaltimes.cn/page/202101/1212939.shtml
My opinions…
Revive Therapeutics (RVVTF) will not publicly release the data on the interim analysis before it’s had a chance to be reviewed by the Independent Data and Safety Monitoring Board (DSMB).
Only after will RVVTF publicly release the data with the DSMB’s review and recommendations, which also may include RVVTF has started the process to file for an Emergency Use Authorization (EUA).
According to the Company's Corporate Presentation the number of Outstanding Shares in November was 240,526,239.
Here it is. Start at 23:30
https://adamanddrdrewshow.com/tag/bucillamine/
My initial thought(s) from watching the price action this morning, (a drop to the .47 cent range from .52 cents), lead me to believe that we might get some news tomorrow but I’m unsure now.
The reason for my initial thought(s) is because of the price action that occurred on December 22, 2020. On December 21, the share price closed within the .53 cent range. The following day, December 22, the share price opened within the .54 cent range and was driven down (by the Market Makers) that morning into the .44 cent range.(...like they knew of pending news and were scooping up shares) The share price consolidated within the .44 cent range throughout the rest of that day. The next morning, December 23, the company released news.
The share price today didn't consolidate on the drop like i thought it would which is why i'm unsure now.
In today's PR the Company announced that "There are currently nine clinical sites participating in the Study with an additional six more clinical sites joining the Study in January to satisfy the overall enrollment goal of up to 1,000 patients".
Question seeking opinion(s): Are these other additional clinical sites going to be located in the USA or could they be located in Canada?
The reason i'm asking is in the December 2nd Company PR it was announced that Dr. Joel Moody was appointed "as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19".
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160414190
"Either Bucillamine or Ivermectin.
I suspect it's the latter."
I didn't call her.
Also, after i posted my original post i felt it to be wise to edit it to remove any speculation about Bucillamine.
Hotmeat may be right about the latter.
BREAKING: Nurse Practitioner gives warning about the mRNA Vaccine.
https://www.brighteon.com/f182bcf8-3aa6-4cea-8f20-e6b5f8020802
Update to ClinicalTrials Website. 1 more site added. 9 in total now.
https://clinicaltrials.gov/ct2/show/NCT04504734
https://clinicaltrials.gov/ct2/history/NCT04504734?A=9&B=10&C=Side-by-Side#StudyPageTop
Allow me to give you a one finger salute before you move on.
…………………./´¯/)
………………..,/¯../
………………./…./
…………./´¯/’…’/´¯¯`•¸
………./’/…/…./……./¨¯\
……..(‘(…´…´…. ¯~/’…’)
………\……………..’…../
……….”…\………. _.•´
…………\…………..(
…………..\………….\…
LG, you get rich yet from your JCPNQ shares?
You still loving your WAMU Escrows?
Very Nice.
I may have been mistaken? InvestorsHub shows it as a "buy".
Great volume. Already surpassed the second highest volume this year which was set on August 3. (30,056,480)
I’m surprised that nobody has mentioned the 1.5 million shares buy from earlier in the day.
Revive's Updated Corporate Presentation for December 2020
http://revivethera.com/investor-relations/
http://revivethera.com/wp-content/uploads/2020/12/RVV-Deck-Dec-2020.pdf
Outstanding Shares still holding at 240,526,239.
Nice volume of shares today - it's the third highest volume this year at +17.9 million shares.
The second highest was on August 3rd with +30 million and the first was on July 31st with +41 million shares traded.
Best of luck to us. Although it's paltry to the amount you have i'm still holding on to my 425,000 shares.
https://nypost.com/2020/12/09/no-drinking-for-two-months-after-covid-19-vaccine-russia-says/
"Russian health officials say the Sputnik V vaccine is over 90 percent effective, but reports say medical workers who have taken the shot have come down with COVID-19. Russian President Vladimir Putin has reportedly refused to take it."
https://nypost.com/2020/11/24/vladimir-putin-wont-take-russias-covid-19-vaccine/
*Edit
Didn't see post 18532. Already disclosed.
Gap filled.
And, has been shown to be 16 times more potent than N-acetylcysteine (NAC).
Not a pump,...but still holding strong to the 425,000 shares i've acquired over the past months. ;)
Translated...
Kyungdong Pharmaceutical acquires permission to export raw materials for COVID-19 treatment 'surge'
[Asia Times = Reporter Kim Ji-ho] The news of the export license of 'Bushiramin', which is being developed overseas as a treatment for Corona 19, is on the rise by Kyungdong Pharmaceutical.
As of 9:34 am on the 30th, Kyungdong Pharmaceutical is recording 13,150 won, a 21.20% increase from the previous trading day.
According to industry sources, Kyungdong Pharmaceutical received a permit for export of bushramin raw materials from the Ministry of Food and Drug Safety on the 26th.
Bushramin is a treatment for rheumatoid arthritis, recently approved by the US Food and Drug Administration (FDA) for a phase 3 clinical trial by Canadian pharmaceutical company Revive Therapeutics to develop it as a treatment for COVID-19.
Like remdesivir, bushramin is expected to re-create a drug for the treatment of Corona 19.
Because, there's no need to make any 'buy' on the open market when they receive 'Options'.
In August of this year, Michael Frank was granted 6 million stock options, exercisable at $.33 until August, 2025.
"Revive would also like to announce that it has granted 6,000,000 stock options to an officer and director. Each option is exercisable at $0.33 per common share at any time until August 5, 2025"
https://www.globenewswire.com/news-release/2020/08/11/2076419/0/en/Revive-Therapeutics-Advancing-Drug-Delivery-Technology-for-Psychedelics.html
I believe i can speak for most who are invested in Revive (RVVTF) that we appreciate the effort. Thanks.
Was that you who got back in with that 500k shares buy?
Here's what clinicaltrials.gov website says about "Last Update Posted"
"The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date."
*The trials may have already started in Nevada prior to today's update.
*edited
According to Revive's October 26 Press Release it was stated that they have "committed to ten clinical sites across Florida, Texas, Nevada, Arizona and California". Prior to today's update on clinicaltrials.gov the only sites listed were in Florida and Texas.
IMO, we will see more updates as Arizona and California are added to complete the "ten clinical sites".
Nevada site was added.
Machuca Family Medicine
Las Vegas, Nevada, United States, 89104
The Corporate Presentation is fixed. It's now showing for November 2020.
https://revivethera.com/investor-relations/
Capital Structure - 240,526,239 Common Shares
As of this posting, the Corporate Presentation showing is for October 2020.
The link i posted yesterday for the PowerPoint Presentation for November 2020 no longer works.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159610307
Side by side comparison of what was updated/changed.
https://clinicaltrials.gov/ct2/history/NCT04504734?A=3&B=4&C=Side-by-Side#StudyPageTop
Tocilizumab is also given intravenously while Bucillamine is in pill form.
Revive's Updated PowerPoint Presentation for November 2020
https://www.revivethera.com/wp-content/uploads/2020/11/RVV-Deck-v1-Nov-2020.pdf
I'm waiting for the PR in which Berman announces that DECN has signed definitive agreements with distributors/dealers to sell moon rocks (GenMoon!), as soon as DECN completes it's designs and build of a rocket which will travel to the moon (in 10.5 seconds) to collect the rocks.